A Phase 2 study of FX101

Trial Profile

A Phase 2 study of FX101

Phase of Trial: Phase II

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs Fluticasone propionate (Primary)
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Flexion Therapeutics
  • Most Recent Events

    • 13 Jul 2017 New trial record
    • 10 Jul 2017 According to a Flexion Therapeutics media release,the company intends to initiate this trial in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top